27431094|t|Chronic cerebral hypoperfusion-induced impairment of Abeta clearance requires HB-EGF-dependent sequential activation of HIF1alpha and MMP9.
27431094|a|Chronic cerebral hypoperfusion (CCH) manifests Alzheimer's Disease (AD) neuropathology, marked by increased amyloid beta (Abeta). Besides, hypoxia stimulates Heparin-binding EGF-like growth factor (HB-EGF) mRNA expression in the hippocampus. However, involvement of HB-EGF in CCH-induced Abeta pathology remains unidentified. Here, using Bilateral Common Carotid Artery Occlusion mouse model, we explored the mechanism of HB-EGF regulated Abeta induction in CCH. We found that HB-EGF inhibition suppressed, while exogenous-HB-EGF triggered hippocampal Abeta, proving HB-EGF-dependent Abeta increase. We also detected that HB-EGF affected the expression of primary Abeta transporters, receptor for advanced glycation end-products (RAGE) and lipoprotein receptor-related protein-1 (LRP-1), indicating impaired Abeta clearance across the blood-brain barrier (BBB). An HB-EGF-dependent loss in BBB integrity supported impaired Abeta clearance. The effect of HB-EGF on Amyloid Precursor Protein pathway was relatively insignificant, suggesting a lesser effect on Abeta generation. Delving into BBB disruption mechanism demonstrated HB-EGF-mediated stimulation of Matrix metalloprotease-9 (MMP9), which affected BBB via HB-EGF-ectodomain shedding and epidermal growth factor receptor activation. Examining the intersection of HB-EGF-regulated pathway and hypoxia revealed HB-EGF-dependent increase in transcription factor, Hypoxia-inducible factor-1alpha (HIF1alpha). Further, via binding to hypoxia-responsive elements in MMP9 gene, HIF1alpha stimulated MMP9 expression, and therefore appeared as a prominent intermediary in HB-EGF-induced BBB damage. Overall, our study reveals the essential role of HB-EGF in triggering CCH-mediated Abeta accumulation. The proposed mechanism involves an HB-EGF-dependent HIF1alpha increase, generating MMP9 that stimulates soluble-HB-EGF/EGFR-induced BBB disintegration. Consequently, CCH-mediated hippocampal RAGE and LRP-1 deregulation together with BBB damage impair Abeta transport and clearance where HB-EGF plays a pivotal role. 
27431094	0	30	Chronic cerebral hypoperfusion	Disease	MESH:D006521
27431094	53	58	Abeta	Gene	11820
27431094	78	84	HB-EGF	Gene	15200
27431094	120	129	HIF1alpha	Gene	15251
27431094	134	138	MMP9	Gene	17395
27431094	140	170	Chronic cerebral hypoperfusion	Disease	MESH:D006521
27431094	172	175	CCH	Disease	MESH:D006521
27431094	187	206	Alzheimer's Disease	Disease	MESH:D000544
27431094	208	210	AD	Disease	MESH:D000544
27431094	262	267	Abeta	Gene	11820
27431094	279	286	hypoxia	Disease	MESH:D000860
27431094	298	336	Heparin-binding EGF-like growth factor	Gene	15200
27431094	338	344	HB-EGF	Gene	15200
27431094	406	412	HB-EGF	Gene	15200
27431094	416	419	CCH	Disease	MESH:D006521
27431094	428	433	Abeta	Gene	11820
27431094	478	519	Bilateral Common Carotid Artery Occlusion	Disease	MESH:D002340
27431094	520	525	mouse	Species	10090
27431094	562	568	HB-EGF	Gene	15200
27431094	579	584	Abeta	Gene	11820
27431094	598	601	CCH	Disease	MESH:D006521
27431094	617	623	HB-EGF	Gene	15200
27431094	663	669	HB-EGF	Gene	15200
27431094	692	697	Abeta	Gene	11820
27431094	707	713	HB-EGF	Gene	15200
27431094	724	729	Abeta	Gene	11820
27431094	762	768	HB-EGF	Gene	15200
27431094	804	809	Abeta	Gene	11820
27431094	824	868	receptor for advanced glycation end-products	Gene	11596
27431094	870	874	RAGE	Gene	11596
27431094	880	918	lipoprotein receptor-related protein-1	Gene	16971
27431094	920	925	LRP-1	Gene	16971
27431094	948	953	Abeta	Gene	11820
27431094	1005	1011	HB-EGF	Gene	15200
27431094	1063	1068	Abeta	Gene	11820
27431094	1094	1100	HB-EGF	Gene	15200
27431094	1104	1129	Amyloid Precursor Protein	Gene	11820
27431094	1198	1203	Abeta	Gene	11820
27431094	1267	1273	HB-EGF	Gene	15200
27431094	1298	1322	Matrix metalloprotease-9	Gene	17395
27431094	1324	1328	MMP9	Gene	17395
27431094	1354	1360	HB-EGF	Gene	15200
27431094	1385	1417	epidermal growth factor receptor	Gene	13649
27431094	1460	1466	HB-EGF	Gene	15200
27431094	1489	1496	hypoxia	Disease	MESH:D000860
27431094	1506	1512	HB-EGF	Gene	15200
27431094	1557	1588	Hypoxia-inducible factor-1alpha	Gene	15251
27431094	1590	1599	HIF1alpha	Gene	15251
27431094	1626	1633	hypoxia	Disease	MESH:D000860
27431094	1657	1661	MMP9	Gene	17395
27431094	1668	1677	HIF1alpha	Gene	15251
27431094	1689	1693	MMP9	Gene	17395
27431094	1760	1766	HB-EGF	Gene	15200
27431094	1836	1842	HB-EGF	Gene	15200
27431094	1857	1860	CCH	Disease	MESH:D006521
27431094	1870	1875	Abeta	Gene	11820
27431094	1925	1931	HB-EGF	Gene	15200
27431094	1942	1951	HIF1alpha	Gene	15251
27431094	1973	1977	MMP9	Gene	17395
27431094	2002	2008	HB-EGF	Gene	15200
27431094	2009	2013	EGFR	Gene	13649
27431094	2056	2059	CCH	Disease	MESH:D006521
27431094	2081	2085	RAGE	Gene	11596
27431094	2090	2095	LRP-1	Gene	16971
27431094	2141	2146	Abeta	Gene	11820
27431094	2177	2183	HB-EGF	Gene	15200
27431094	Positive_Correlation	MESH:D000860	15200
27431094	Association	MESH:D006521	15200
27431094	Association	11820	15251
27431094	Association	15200	15251
27431094	Association	MESH:D000860	17395
27431094	Association	11820	16971
27431094	Positive_Correlation	15200	17395
27431094	Association	MESH:D006521	17395
27431094	Positive_Correlation	11820	15200
27431094	Association	MESH:D006521	15251
27431094	Association	11820	17395
27431094	Positive_Correlation	MESH:D006521	11820
27431094	Positive_Correlation	15251	17395
27431094	Association	MESH:D000860	15251
27431094	Association	11596	11820
27431094	Association	11596	15200
27431094	Association	15200	16971
27431094	Association	13649	15200
27431094	Association	13649	17395
27431094	Positive_Correlation	MESH:D000544	11820

